Technical Analysis for PSTX - Poseida Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Support | Bullish | 0.00% | |
200 DMA Support | Bullish | 0.00% | |
50 DMA Support | Bullish | 0.00% | |
Up 3 Days in a Row | Strength | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% | |
50 DMA Support | Bullish | 3.08% | |
Crossed Above 20 DMA | Bullish | 3.08% | |
Crossed Above 200 DMA | Bullish | 3.08% | |
MACD Bullish Signal Line Cross | Bullish | 3.08% | |
Pocket Pivot | Bullish Swing Setup | 3.08% |
Alert | Time |
---|---|
Rose Above Upper Bollinger Band | about 5 hours ago |
Up 3% | about 5 hours ago |
Rose Above Previous Day's High | about 6 hours ago |
60 Minute Opening Range Breakout | about 9 hours ago |
Up 2% | about 9 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/06/2024
Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in 2014 and is headquartered in San Diego, CA.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Clinical Medicine Life Sciences Solid Tumors Immune System Cancer Treatment Lymphoma Leukemia Chimeric Antigen Receptor T Cell Hematological Malignancies Chimeric Antigen Receptor Cellectis
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Clinical Medicine Life Sciences Solid Tumors Immune System Cancer Treatment Lymphoma Leukemia Chimeric Antigen Receptor T Cell Hematological Malignancies Chimeric Antigen Receptor Cellectis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 4.27 |
52 Week Low | 1.58 |
Average Volume | 521,637 |
200-Day Moving Average | 2.83 |
50-Day Moving Average | 2.75 |
20-Day Moving Average | 2.76 |
10-Day Moving Average | 2.73 |
Average True Range | 0.23 |
RSI (14) | 57.08 |
ADX | 11.13 |
+DI | 23.90 |
-DI | 16.61 |
Chandelier Exit (Long, 3 ATRs) | 2.40 |
Chandelier Exit (Short, 3 ATRs) | 3.11 |
Upper Bollinger Bands | 3.04 |
Lower Bollinger Band | 2.48 |
Percent B (%b) | 0.94 |
BandWidth | 20.27 |
MACD Line | -0.01 |
MACD Signal Line | -0.03 |
MACD Histogram | 0.0217 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 3.51 | ||||
Resistance 3 (R3) | 3.47 | 3.26 | 3.43 | ||
Resistance 2 (R2) | 3.26 | 3.14 | 3.28 | 3.40 | |
Resistance 1 (R1) | 3.14 | 3.06 | 3.20 | 3.18 | 3.37 |
Pivot Point | 2.93 | 2.93 | 2.96 | 2.95 | 2.93 |
Support 1 (S1) | 2.80 | 2.80 | 2.87 | 2.84 | 2.65 |
Support 2 (S2) | 2.59 | 2.72 | 2.61 | 2.62 | |
Support 3 (S3) | 2.47 | 2.59 | 2.59 | ||
Support 4 (S4) | 2.51 |